Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: A pilot study

American Journal of Nephrology

Volumn 30, Issue 3, 2009, Pages 253-260

  Song, Young Rim ^a   Lee, Taewoo ^b   You, Sun Jin ^b   Chin, Ho Joon ^b,e   Chae, Dong Wan ^b,e   Lim, Cheong ^c,e   Park, Kay Hyun ^c,e   Han, Sunghee ^d,e   Kim, Jin Hee ^d,e   Na, Ki Young ^b,e  

^a Hallym University   (South Korea)

^b Department of Internal Medicine ^*

^c Thoracic and Cardiovascular Surgery   (United States)

^d Seoul National University Bundang Hospital   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Acute renal failure; Cardiovascular; Erythropoietin

Indexed keywords

CREATININE; PLACEBO; RECOMBINANT ERYTHROPOIETIN; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HEART SURGERY; HUMAN; KIDNEY FUNCTION; KIDNEY INJURY; MALE; MORTALITY; PILOT STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; ERYTHROPOIETIN; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 66149129192     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000223229     Document Type: Article

References (46)

1. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31.
2. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT; The Multicenter Study of Perioperative Ischemia Research Group: Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med 1998; 128: 194-203.
3. Tuttle KR, Worrall NK, Dahlstrom LR, Nandagopal R, Kausz AT, Davis CL: Predictors of ARF after cardiac surgical procedures. Am J Kidney Dis 2003; 41: 76-83.
4. Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP, Landolfo K: Acute renal failure following cardiac surgery. Nephrol Dial Transplant 1999; 14: 1158-1162.
5. Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, Ferguson TB Jr, Grover FL, Edwards FH; The Society of Thoracic Surgeons: Thirty-day operative mortality and morbidity risk models. Ann Thorac Surg 2003; 75: 1856-1864.
6. Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J: Preoperative renal risk stratification. Circulation 1997; 95: 878-884.
7. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M: Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004; 15: 1597-1605.
8. Loef BG, Epema AH, Smilde TD, Henning RH, Ebels T, Navis G, Stegeman CA: Immediate postoperative renal function deterioration in cardiac surgical patients predicts inhospital mortality and long-term survival. J Am Soc Nephrol 2005; 16: 195-200.
9. Garwood S: Renal insufficiency after cardiac surgery. Semin Cardiothorac Vasc Anesth 2004; 8: 227-241.
10. Marathias KP, Vassili M, Robola A, Alivizatos PA, Palatianos GM, Geroulanos S, Vlahakos DV: Preoperative intravenous hydration confers renoprotection in patients with chronic kidney disease undergoing cardiac surgery. Artif Organs 2006; 30: 615-621.
11. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M: Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000; 11: 97-104.
12. Lombardi R, Ferreiro A, Servetto C: Renal function after cardiac surgery: adverse effect of furosemide. Ren Fail 2003; 25: 775-786.
13. Ho KM, Sheridan DJ: Meta-analysis of furosemide to prevent or treat acute renal failure. BMJ 2006; 333: 420.
14. Woo EB, Tang AT, el-Gamel A, Keevil B, Greenhalgh D, Patrick M, Jones MT, Hooper TL: Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: science or fiction? Eur J Cardiothorac Surg 2002; 22: 106-111.
15. Argalious M, Motta P, Khandwala F, Samuel S, Koch CG, Gillinov AM, Yared JP, Starr NJ, Bashour CA: 'Renal dose' dopamine is associated with the risk of new-onset atrial fibrillation after cardiac surgery. Crit Care Med 2005; 33: 1327-1332.
16. Burns KE, Chu MW, Novick RJ, Fox SA, Gallo K, Martin CM, Stitt LW, Heidenheim AP, Myers ML, Moist L: Perioperative N -acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: a randomized controlled trial. JAMA 2005;294: 342-350.
17. Ristikankare A, Kuitunen T, Kuitunen A, Uotila L, Vento A, Suojaranta-Ylinen R, Salmenperä M, Pöyhiä R: Lack of renoprotective effect of intravenous N -acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Br J Anaesth 2006; 97: 611-616.
18. Swärd K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE: Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 2004; 32: 1310-1315.
19. Chen HH, Sundt TM, Cook DJ, Heublein DM, Burnett JC Jr: Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study. Circulation 2007; 116(suppl I):I134-I138.
20. Mentzer RM Jr, Oz MC, Sladen RN, Graeve AH, Hebeler RF Jr, Luber JM Jr, Smedira NG: Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA Trial. J Am Coll Cardiol 2007; 49: 716-726.
21. Kaya K, Oduz M, Akar AR, Durdu S, Aslan A, Erturk S, Taöz R, Ozyurda U: The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial. Eur J Cardiothorac Surg 2007; 31: 290-297.
22. Maiese K, Li F, Chong ZZ: New avenues of exploration for erythropoietin. JAMA 2005; 293: 90-95.
23. Chatterjee PK: Pleiotropic renal actions of erythropoietin. Lancet 2005; 365: 1890-1892.
24. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
25. Bertolissi M, Antonucci F, De Monte A, Padovani R, Giordano F: Effects on renal function of a continuous infusion of nifedipine during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1996; 10: 238-242.
26. Kulka PJ, Tryba M, Zenz M: Preoperative 2 -adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med 1996; 24: 947-952.
27. Abe K, Sakakibara T, Yoshiya I: The effect of prostaglandin E 1 on renal function after cardiac surgery involving cardiopulmonary bypass. Prostaglandins Leukot Essent Fatty Acids 1993; 49: 627-631. (Pubitemid 23236524)
28. Caimmi PP, Pagani L, Micalizzi E, Fiume C, Guani S, Bernardi M, Parodi F, Cordero G, Fregonara M, Kapetanakis E, Panella M, Degasperis C: Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2003; 17:491-494.
29. Ranucci M, Soro G, Barzaghi N, Locatelli A, Giordano G, Vavassori A, Manzato A, Melchiorri C, Bove T, Juliano G, Uslenghi MF: Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg 2004; 78: 1332-1337.
30. Zanardo G, Michielon P, Rosi P, Teodori T, Antonucci F, Caenaro G, Michieletto F, Simini G: Effects of a continuous diltiazem infusion on renal function during cardiac surgery. J Cardiothorac Vasc Anesth 1993; 7: 711-716.
31. Bergman AS, Odar-Cederlöf I, Westman L, Bjellerup P, Höglund P, Ohqvist G: Diltiazem infusion for renal protection in cardiac surgical patients with preexisting renal dysfunction. J Cardiothorac Vasc Anesth 2002; 16: 294-299.
32. Boldt J, Brosch C, Piper SN, Suttner S, Lehmann A, Werling C: Influence of prophylactic use of pentoxifylline on postoperative organ function in elderly cardiac surgery patients. Crit Care Med 2001; 29: 952-958. (Pubitemid 32424344)
33. Boldt J, Brosch C, Lehmann A, Suttner S, Isgro F: The prophylactic use of the-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients. Anesth Analg 2004; 99: 1009-1017.
34. Aluclu MU, Acar A, Guzel A, Bahceci S, Yaldiz M: Evaluation of erythropoietin effects on cerebral ischemia in rats. Neuroendocrinol Lett 2007; 28: 170-174.
35. Lipsic E, Schoemaker RG, van der Meer P, Voors AA, van Veldhuisen DJ, van Gilst WH: Protective effects of erythropoietin in cardiac ischemia: from bench to bedside. J Am Coll Cardiol 2006; 48: 2161-2167.
36. Sepodes B, Maio R, Pinto R, Sharples E, Oliveira P, McDonald M, Yaqoob M, Thiemermann C, Mota-Filipe H: Recombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the rat. Transpl Int 2006; 19: 919-926.
37. Wu H, Ren B, Zhu J, Dong G, Xu B, Wang C, Zheng X, Jing H: Pretreatment with recombined human erythropoietin attenuates ischemia-reperfusion-induced lung injury in rats. Eur J Cardiothorac Surg 2006; 29: 902-907.
38. Chatterjee PK, Todorovic Z, Sivarajah A, Mota-Filipe H, Brown PA, Stewart KN, Mazzon E, Cuzzocrea S, Thiemermann C: Inhibitors of calpain activation (PD150606 and E- 64) and renal ischemia-reperfusion injury. Biochem Pharmacol 2005; 69: 1121-1131.
39. Johnson DW, Forman C, Vesey DA: Novel renoprotective actions of erythropoietin: new uses for an old hormone. Nephrology 2006; 11: 306-312.
40. Sharples EJ, Thiemermann C, Yaqoob MM: Mechanisms of disease: cell death in acute renal failure and emerging evidence for a protective role of erythropoietin. Nat Clin Pract Nephrol 2005; 1: 87-97.
41. Shaskey DJ, Green GA: Sports haematology. Sports Med 2000; 29: 27-38.
42. Wun T, Law L, Harvey D, Sieracki B, Scudder SA, Ryu JK: Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin. Cancer 2003; 98: 1514-1520.
43. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Rüther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Sirén AL: Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002; 8: 495-505.
44. McCullough PA: Contrast-induced acute kidney injury. J Am Coll Cardiol 2008; 51: 1419-1428.
45. Pannu N, Wiebe N, Tonelli M, Alberta Kidney Disease Network: Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006; 295: 2765-2779.
46. Antunes PE, Prieto D, Ferrão de Oliveira J, Antunes MJ: Renal dysfunction after myocardial revascularization. Eur J Cardiothorac Surg 2004; 25: 597-604.